Charles Schwab Investment Management Inc Enzo Biochem Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Enzo Biochem Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 13,471 shares of ENZ stock, worth $14,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,471

Previous 13,471 -0.0%

Holding current value

$14,548

Previous $14,000 7.14%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.86 - $3.61 $264,658 - $334,062	-92,538 Reduced 87.29%	13,471 $43,000
Q3 2020 Nov 13, 2020	SELL	$2.02 - $3.02 $318,782 - $476,595	-157,813 Reduced 59.82%	106,009 $224,000
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.22 $33,402 - $50,734	15,756 Added 6.35%	263,822 $591,000
Q1 2020 May 15, 2020	BUY	$1.82 - $3.87 $6,302 - $13,401	3,463 Added 1.42%	248,066 $628,000
Q4 2019 Feb 07, 2020	BUY	$2.57 - $3.68 $6,885 - $9,858	2,679 Added 1.11%	244,603 $644,000
Q3 2019 Nov 08, 2019	SELL	$3.01 - $4.0 $37,345 - $49,628	-12,407 Reduced 4.88%	241,924 $871,000
Q2 2019 Aug 09, 2019	BUY	$2.79 - $4.31 $61,815 - $95,492	22,156 Added 9.54%	254,331 $858,000
Q1 2019 May 14, 2019	SELL	$2.54 - $4.02 $2,534 - $4,011	-998 Reduced 0.43%	232,175 $634,000
Q4 2018 Feb 14, 2019	SELL	$2.46 - $4.2 $7,842 - $13,389	-3,188 Reduced 1.35%	233,173 $649,000
Q3 2018 Nov 13, 2018	BUY	$3.81 - $5.53 $55,134 - $80,024	14,471 Added 6.52%	236,361 $974,000
Q2 2018 Aug 08, 2018	BUY	$5.06 - $6.78 $35,536 - $47,615	7,023 Added 3.27%	221,890 $1.15 Million
Q1 2018 May 07, 2018	BUY	$5.43 - $8.36 $200,752 - $309,077	36,971 Added 20.78%	214,867 $1.18 Million
Q4 2017 Jan 17, 2018	SELL	$8.15 - $10.55 $183,815 - $237,944	-22,554 Reduced 11.25%	177,896 $1.45 Million
Q3 2017 Nov 13, 2017	BUY	$10.45 - $11.44 $2.09 Million - $2.29 Million	200,450	200,450 $2.1 Million

Others Institutions Holding ENZ

# of Institutions

Shares Held

15.5M

Call Options Held

2.3K

Put Options Held

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $52.6M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Enzo Biochem Inc Transaction History